Evidence map›Paper›PMID 37608143›Full record

ArticleInternational microbiology : the official journal of the Spanish Society for Microbiology2024

In-vitro screening of compatible synbiotics and (introducing) "prophybiotics" as a tool to improve gut health.

Ramesha N Wishna-Kadawarage, Martin Jensen, Szymon Powałowski, Rita M Hickey, Maria Siwek

Open access · hybridAbstract read
In one paragraph

Article in International microbiology : the official journal of the Spanish Society for Microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Comparative Analysis ofMolecules (Basel, Switzerland) · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Ramesha N Wishna-KadawarageDepartment of Animal Biotechology and Genetics, Faculty of Animal Breeding and Biology, Bydgoszcz University of Science and Technology, Mazowiecka 28, 85-084, Bydgoszcz, Poland. ramesha.wishna-kadawarage@pbs.edu.pl.ORCID http://orcid.org/0000-0003-3144-1186
Martin JensenDepartment of Food Science, Aarhus University, AgroFoodPark 48, 8200, Århus N, Denmark.ORCID http://orcid.org/0000-0002-6593-4870
Szymon PowałowskiUniveristy of Humanities Król Stanisław Leszczyński, Królowej Jadwigi 10, 64-100, Leszno, Poland.ORCID http://orcid.org/0000-0002-9016-6666
Rita M HickeyTeagasc Food Research Centre, Moorepark, Fermoy, P61 C996, Co. Cork, Ireland.ORCID http://orcid.org/0000-0002-2128-2575
Maria SiwekDepartment of Animal Biotechology and Genetics, Faculty of Animal Breeding and Biology, Bydgoszcz University of Science and Technology, Mazowiecka 28, 85-084, Bydgoszcz, Poland.ORCID http://orcid.org/0000-0003-4148-5174
Bydgoszcz University of Science and Technology · PLAarhus University · DKTeagasc - The Irish Agriculture and Food Development Authority · IE

Funding

European Union's Horizon 2020 research and innovation programme (Monoguthealth MSCA-ITN project) Grant agreement No 955374.
6 · The paper itself

Abstract

Synbiotics have been intensively studied recently to improve gut health of humans and animals. The success of synergistic synbiotics depends on the compatibility of the prebiotic and probiotic components. Certain plant extracts possess both antimicrobial and prebiotic properties representing a potential use in combination with probiotics to improve the gut health. Here, we coined the term "prophybiotics" to describe this combined bioactivity. The current study aimed to select prebiotics that are preferred as an energy source and antimicrobial plant extracts which do not inhibit the growth, of six strains of lactic acid bacteria (LAB namely; Lactiplantibacillus plantarum, Lacticaseibacillus casei, Limosilactobacillus reuteri, Lacticaseibacillus rhamnosus, Leuconostoc mesenteroides, and Pediococcus pentosaceus) in-vitro to identify compatible combinations for potential synbiotic/prophybiotic use, respectively. Their growth kinetics were profiled in the presence of prebiotics: Inulin, Raffinose, and Saccharicterpenin with glucose, as the control, using carbohydrate free MRS broth media. Similarly, their growth kinetics in MRS broth supplemented with turmeric, green tea, and garlic extracts at varying concentrations were profiled. The results revealed the most compatible pairs of prebiotics and LAB. Turmeric and garlic had very little inhibitory effect on the growth of the LAB while green tea inhibited the growth of all LAB in a dose-dependent manner. Therefore, we conclude that turmeric and garlic have broad potential for use in prophybiotics, while the prebiotics studied here have limited use in synbiotics, with these LAB.

Indexed as

Plant ExtractsPrebioticsSynbioticsGastrointestinal MicrobiomeHumansLactobacillalesProbioticsPlant ExtractsPrebioticsAntimicrobialGompertz modelGrowth kineticsPlant extractsPrebioticsProbiotics

Identifiers

PMID37608143
PMCPMC11144166
OpenAlexW4386047629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.